Published in:
01-09-2018 | Correction
Correction to: Radioembolization for Hepatocellular Carcinoma Arising in the Setting of a Congenital Extrahepatic Portosystemic Shunt (Abernethy Malformation)
Published in: CardioVascular and Interventional Radiology | Issue 9/2018
Login to get accessExcerpt
Table 1, which appears below, was inadvertently left out of the published article.
Table 1
Summary of cases with Abernethy malformation Type 1 in association with HCC
|
N
|
Author
|
Type of CEPS and additional features
|
Age
|
Gender
|
Histology
|
Therapy
|
|---|---|---|---|---|---|---|
|
1
|
Joyce et al., Br J Surg 1988; 75:1038–1039
|
Ib, coarctation of the aorta and patent ductus arteriosus
|
10
|
Female
|
HCC (G1)
|
Hepatic resection
|
|
2
|
Taïeb et al. Gastroenterol Clin Biol. 1998 Feb;22(2):246–247
|
I
|
Unknown
|
Unknown
|
HCC
|
Unknown
|
|
3
|
Lundstedt et al., Eur Radiol 2001; 11:2228–2231
|
Ib, Hepatitis B
|
51
|
Male
|
HCC, liver cirrhosis
|
Hepatic resection
|
|
4
|
Pichon et al., JPN J Clin Oncol 2003; 33(6):314–316
|
Ia
|
36
|
Female
|
HCC, no liver cirrhosis
|
Hepatic resection
|
|
5
|
Morotti et al., Semin Liver Dis 2007; 27:427–432
|
Ib, associated Turner syndrome
|
8
|
Female
|
HCC (G1), no liver cirrhosis
|
OLT
|
|
6
|
Lisovsky et al., Am J Surg Pathol 2011; 35:1381–1390
|
Ib
|
47
|
Male
|
HCC (G2), no liver cirrhosis
|
MWA and DEB-TACE
|
|
7
|
Ib
|
53
|
Male
|
HCC (G2), no liver cirrhosis
|
Hepatic resection
|
|
|
8
|
Scheuermann et al., Transpl Int. 2012;25(5):e67–e68
|
Ia
|
38
|
Female
|
HCC (G2), no liver cirrhosis
|
Hepatic resection followed by OLT
|
|
9
|
Gordon-Burroughs et al., Transplant Proc. 2014;46(7):2418–2421
|
Ib
|
61
|
Female
|
HCC (G2), no liver cirrhosis
|
Resection and OLT after recurrence in adenomatosis
|
|
10
|
Sharma et al., Hepatobiliary Pancreat Dis Int 2015;14:552–557
|
Ib, additional multiple FNH
|
31
|
Female
|
HCC (G3), no liver cirrhosis
|
TAE und MWA
|
|
11
|
Ib
|
49
|
Male
|
HCC (G2), no liver cirrhosis
|
Sorafenib
|
|
|
12
|
Ib
|
29
|
Male
|
HCC (G2), no liver cirrhosis
|
TAE followed by Sorafenib
|
|
|
13
|
Tacyildiz et al. J Clin Case Rep 2015; 5:504
|
Ib
|
5
|
Female
|
HCC, no liver cirrhosis
|
Right hepatectomy
|
|
14
|
Happaerts et al., Hepatology 2016;64(5):1800–1802
|
Ib, associated tetralogy of Fallot
|
27
|
Female
|
HCC-CC (G2)
|
Hepatic resection
|
|
15
|
Bendict et al., Pediatr Dev Pathol. 2017 20(4):354–362
|
Ib
|
1
|
Female
|
HCC, no liver cirrhosis
|
OLT
|
|
16
|
Current case
|
Ib
|
50
|
Male
|
HCC (G1), no liver cirrhosis
|
TARE, left hepatectomy
|